The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
Category: Moderna
More than 3,700 cases of mpox have been identified in the UK since May 2022
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359